CTOs on the Move

AxioMed Spine Corporation

www.axiomed.com

 
AxioMed was founded to advance the standard of care for patients with degenerative spine conditions by progressing spine technology beyond fusion and first-generation artificial discs. Led by an experienced surgeon team and utilizing patented viscoelastic polymer technology, AxioMed has developed the next generation of artificial discs.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

AxioMed Spine Corporation raised $10M on 10/09/2017

Similar Companies

SAINT MARYS REGIONAL MEDICAL CENTER

SAINT MARYS REGIONAL MEDICAL CENTER is a Lewiston, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Blooma

Blooma nourishes the mind, body and spirit of moms-to-be, new mamas and their families through yoga, barre and childbirth education classes.

Baker and Cadra A Professional Dental

Baker and Cadra A Professional Dental is a Modesto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Universal Pediatrics

Universal Pediatrics is a company that provides in-home healthcare and private duty nursing services for children and young adults with serious medical conditions.

Dimension Therapeutics

Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.